Aethlon Medical (AEMD) EBT (2010 - 2026)

Aethlon Medical (AEMD) has reported EBT for 17 consecutive years, with -$1.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT rose 10.06% year-over-year to -$1.6 million; the trailing twelve-month figure through Jun 2026 stood at -$7.1 million (up 13.94% YoY), and the FY2026 full-year result was -$7.2 million, up 47.81% from the prior year.
• EBT grew to -$1.6 million in Q2 2026 per AEMD's latest filing, from -$1.9 million in the prior quarter.
• Across five years, EBT topped out at -$1.5 million in Q3 2025 and bottomed at -$3.8 million in Q1 2022.
• Historically, EBT has averaged -$2.5 million across 5 years, with a median of -$2.5 million in 2023.
• The sharpest annual moves came in 2022 and 2024: EBT plunged 82.46% in 2022, then jumped 49.37% in 2024.
• Over 5 years, EBT stood at -$2.8 million in 2022, then fell by 21.63% to -$3.5 million in 2023, then soared by 49.37% to -$1.8 million in 2024, then fell by 17.51% to -$2.1 million in 2025, then gained by 23.42% to -$1.6 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$1.6 million, -$1.9 million, and -$2.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.